Flu vax tender update
June 11, 2014
IN RESPONSE to queries received,
the Department of Health has
published further information
about its pre-release notice
regarding an open tender for the
supply of Australian antivenoms,
Q fever and/or pandemic influenza
vaccine (PD 21 May) on the
Austender website.
The Department said its supply
arrangements for Australian
antivenoms, Q fever and/or
pandemic influenza vaccine were
due to expire on 30 Jun 2016.
In the addendum to its prerelease
notice, the Department
said it intended to host an
industry briefing to provide more
information on tender timing and
requirements, expected to be in
late August or early September.
The tender was expected to be
released in about September and
submissions would be due in mid-
December, it said.
There were 11 antivenoms
manufactured for a range of
Australian animals and marine life
including the Box Jellyfish, the Red
Back spider and the Tiger snake and
that the scope of products “need
not necessarily be restricted to the
above list but production capacity/
capability would need to be
flexible to meet Australian market
demand,” it said.
The successful tenderer for
vaccine supply would need to
have manufacturing capacity and
capability for circulating influenza
virus strains with pandemic
potential or a specific strain and the
Australian demographic.
Both the Q fever vaccine and
skin test would be required, the
Department said.
Funds had been allocated across
the 2014-15 to 2017-18 financial
years, it said.
“The open tender process will
result in a new contract(s) to
ensure Australia a timely and
assured supply of the three
products post expiry of the current
arrangements.”
For more, CLICK HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 11 Jun 14To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Jun 14
